Publicaciones en las que colabora con Alberto Ocaña (26)

2021

  1. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 764-772

  2. Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer

    Frontiers in Oncology, Vol. 11

2020

  1. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population

    Cancers, Vol. 11, Núm. 4

2015

  1. Outcomes of estrogen receptor negative and progesterone receptor positive breast cancer

    PLoS ONE, Vol. 10, Núm. 7

2009

  1. New targeted therapies in head and neck cancer

    Cancer and Chemotherapy Reviews, Vol. 4, Núm. 1, pp. 35-43

2008

  1. New options in the treatment of locally advanced head and neck cancer: Role for induction chemotherapy

    Cancer Treatment Reviews, Vol. 34, Núm. 3, pp. 268-274

  2. Third nerve palsy as the initial presenting sign of metastatic prostate cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 31, Núm. 4, pp. 407-408

2007

  1. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients

    Cancer Letters, Vol. 255, Núm. 1, pp. 71-76

  2. Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663

  3. Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer

    Annals of Oncology, Vol. 18, Núm. 3, pp. 421-430

  4. Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration [1]

    Journal of Palliative Medicine

2006

  1. Case 3. Upper limb lymphangiosarcoma following breast cancer therapy

    Journal of Clinical Oncology, Vol. 24, Núm. 9, pp. 1477-1478

  2. Trastuzumab and antiestrogen therapy: Focus on mechanisms of action and resistance

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 29, Núm. 1, pp. 90-95

2005

  1. Afectación metastásica del sistema nervioso central en el cáncer de mama: Papel del Herceptin

    Revista Clinica Espanola, Vol. 205, Núm. 11, pp. 553-555

  2. Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer

    Clinical and Translational Oncology

  3. Historia natural del cáncer de tiroides

    Revisiones en Cancer, Vol. 19, Núm. 4, pp. 163-170

  4. Integrating trastuzumab in the treatment of breast cancer. Current status and future trends

    Clinical and Translational Oncology

  5. Metastatic prostate cancer with a normal prostate-specific antigen level

    Clinical and Translational Oncology, Vol. 7, Núm. 9, pp. 412-413

  6. Taponamiento cardíaco como forma de presentación de un tumor de origen desconocido: Abuso en las pruebas diagnósticas

    Oncologia, Vol. 28, Núm. 6, pp. 39-42